Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA, INFECÇÕES POR HIV, FARMACOTERAPIA, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women. The Journal of Clinical Pharmacology, v. 63, n. 9, p. 1053-1060, 2023Tradução . . Disponível em: https://doi.org/10.1002/jcph.2287. Acesso em: 27 jan. 2026.APA
Moreira, F. de L., Paz, T. A., Melli, P. P. dos S., Thomaz, M. de L., Marques, M. P., Rocha, A., et al. (2023). Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women. The Journal of Clinical Pharmacology, 63( 9), 1053-1060. doi:10.1002/jcph.2287NLM
Moreira F de L, Paz TA, Melli PP dos S, Thomaz M de L, Marques MP, Rocha A, Duarte G, Lanchote VL. Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 9): 1053-1060.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1002/jcph.2287Vancouver
Moreira F de L, Paz TA, Melli PP dos S, Thomaz M de L, Marques MP, Rocha A, Duarte G, Lanchote VL. Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 9): 1053-1060.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1002/jcph.2287
